ResearchForecast

  During the forecast period 2023-2033, the  DNA Methylation Market  is expected to grow at a value of 15% CAGR, according to Future Market Insights. By the year 2033, the global market for DNA methylation is expected to rise up to a market valuation of US$ 5815.49 Million.  Furthermore, the growing prevalence of esophageal adenocarcinoma has contributed to the overall growth. According to the data published by the American Cancer Society (ACS), in 2022, an estimated 20,640 esophageal cancer cases were undiagnosed in the U.S. The chronic disease. resulted in 16,410 deaths. Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15893 Growing esophageal cancer cases in the U.S. highlight the urgent need for early intervention measures that can help improve the low survival rates for patients. In October 2022, a research article published by Fred Hutchinson Cancer Center stated that methylated DNA biomarkers could be used for the...

  The global DNA Methylation Market is expected to generate a market value of US$ 1437.5 Million in 2023 and a market value of US$ 5815.49 Million by 2033, with a CAGR of 15% from 2023 to 2033. The increasing number of cancer cases worldwide remains the primary driver of the DNA methylation market's expected growth. In the historical period 2016 to 2021, the market for DNA methylation grew at a CAGR of 11%. To learn more about this report @ https://www.futuremarketinsights.com/reports/dna-methylation-market The significant increase in the adoption of epigenetics-based treatment strategies, coupled with the broad nucleic acid-based diagnostic tests & kits commercialization is projected to drive the growth of the market. In May 2022, an article published in PubMed stated that the epigenetics-based treatment strategies are to be used for studying Alzheimer’s disease. Moreover, Key players operating in the market are taking several initiatives such as new product development...